Moderna, Inc. (NAS: MRNA) Stock Analysis & Fundamentals

MRNAModerna, Inc.

NAS · US · Healthcare · Biotechnology · modernatx.com

63.15USD-7.51%Mkt Cap: 25.06B $P/E: —1d ago

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal in…

Headline	Source	Time
Today
Neglected Quant Safety Trade Makes a Comeback as AI Risks Rise (Bloomberg) -- As worries build around the artificial intelligence trade, investors are starting to seek shelter in a more pedestrian corner of the stock market: companies with sturdy finances.Most Read from BloombergThailand Scraps Plan to End Visa-Free Entry for Indian TouristsGoogle Gemini Launch Delayed as Tech Falls Short of Internal GoalsBeckham’s IM8 Gets $1 Billion From General Catalyst for GrowthNasdaq Futures Tumble 1.5% as Chip Rout Deepens: Markets WrapUS Cyclospora Outbreak Tied to	Bloomberg	4h
Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances The new lawsuits add to a web of legal disputes over technology involved in COVID vaccines. Elsewhere, a prolific AI biotech inked another deal and Insmed strengthened support for a closely watched blood pressure drug.	BioPharma Dive	5h
Yesterday
ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection? On July 8, Arbutus received around $178 million from Moderna as part of a patent litigation settlement, the company said.	Stocktwits	21h
This week
Moderna set for uneventful Q2 report ahead of key data readouts, says Jefferies Moderna Inc (NASDAQ:MRNA, XETRA:0QF) is expected to report second quarter results on July 31, with investors focused on the impact of seasonal COVID-19 vaccine demand and updates on the company’s late-stage pipeline, including anticipated Phase III melanoma data. Jefferies analysts expect a...	Proactive	Jul 14
Moderna (MRNA) Registers a Bigger Fall Than the Market: Important Facts to Note Moderna (MRNA) reached $66.98 at the closing of the latest trading day, reflecting a -1.89% change compared to its last close.	Zacks	Jul 13
What It Means To Hold Moderna Stock In A Crash	Trefis	Jul 13
Moderna, Takeda and Capricor on the verge of notching big drug approvals	Pharma Voice	Jul 13
US Stock Market Today: S&P 500 Futures Rise As Inflation Cools And Earnings Loom	Simply Wall St.	Jul 13
Older
Stock Market Today: Dow Ends Higher; SK Hynix Jumps In U.S. Trading Debut; Moderna Tumbles	Investor's Business Daily	Jul 10
Update: US Equity Indexes Rise as Diplomatic Engagements Between Washington, Iran Send Crude Oil Lower	MT Newswires	Jul 10
Update: US Equities Rise, Oil Prices Ease as Trump Confirms Iran Talks	MT Newswires	Jul 10
MRNA Stock Eyes Worst Week In 11 Months After June Surge — What’s Ahead?	Stocktwits	Jul 10
Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout	24/7 Wall St.	Jul 10
Only 1 Major S&P 500 Sector Is Really Struggling Today	Barrons.com	Jul 10
Why Moderna (MRNA) Stock Is Trading Up Today	StockStory	Jul 9
Moderna (MRNA) Stock May Sit Above Fair Value Following Pipeline Expansion	Simply Wall St.	Jul 9
Moderna secures up to 24 million RSV vaccine dose contract with Europe	Pharmaceutical Technology	Jul 9
RBC Capital Raises its Price Target on Moderna (MRNA)	Insider Monkey	Jul 9
Will New Board Appointment And mRNA Flu Progress Change Moderna's (MRNA) Pipeline Diversification Narrative?	Simply Wall St.	Jul 9
Update: Dow Logs Worst Day in 4 Weeks Amid Renewed US-Iran Tensions	MT Newswires	Jul 8
US Equity Markets Mixed After Trump Warns of Additional Strikes on Iran	MT Newswires	Jul 8
Why Moderna Stock Is the S&P 500’s Big Loser Today	Barrons.com	Jul 8
Update: Wall Street Falls Intraday as Trump Threatens to Hit Iran Again	MT Newswires	Jul 8
Momentum ETFs Are Actually Holding Up	Barrons.com	Jul 8
Biopharma Companies' Second-Half Performance to be Largely Driven by Fundamentals, Morgan Stanley Says	MT Newswires	Jul 8
Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says	MT Newswires	Jul 8
Dow Jones and Nasdaq start lower as Trump says Iran ceasefire 'over'	Proactive	Jul 8
ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week	Stocktwits	Jul 7
Moderna, TG Therapeutics, Agios Pharmaceuticals Q2 Results May Face Increased Scrutiny, BofA Says	MT Newswires	Jul 7
Moderna Stock Is Soaring. Is It Too Late to Buy?	Motley Fool	Jul 7
Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know	Zacks	Jul 6
US Stock Market Today: S&P 500 Futures Rise As Inflation Jitters Temporarily Ease	Simply Wall St.	Jul 6
Jim Cramer Says “For the First Time in Ages, I Like Having a Position in Moderna”	Insider Monkey	Jul 4
Stock Market Week Ahead: Oil Hints At A Paradigm Shift	Investor's Business Daily	Jul 4
MarketBeat Week in Review – 06/29 - 07/03	MarketBeat	Jul 4
Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%. What Gives?	Motley Fool	Jul 3
Jim Cramer turns bullish on health care stock after years of doubt	TheStreet	Jul 3
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?	Motley Fool	Jul 3
MRNA Stock on the Move: What Sparked the 33.5% Jump in the Past Week?	Zacks	Jul 3
3 Cash-Heavy Stocks with Warning Signs	StockStory	Jul 3
US Stock Market Today: S&P 500 Futures Slip On Cooling Jobs And Rate Jitters	Simply Wall St.	Jul 3
Tesla, Rivian, Strategy, Moderna, Sandisk, Blue Owl, and More Stocks That Explain Today’s Market	Barrons.com	Jul 2
Why Did PANW, AAL, MRNA Surge To 52-Week Highs?	Stocktwits	Jul 2
Sandisk Leads Seven S&P 500 Stocks That Have Skyrocketed In 2026	Investor's Business Daily	Jul 1
Short Squeeze Alert—Moderna Stock Surges on New Strategy	MarketBeat	Jul 1
The 20 best-performing stocks in the S&P 500 for the first half of 2026	MarketWatch	Jun 30
Is Moderna Stock a No-Brainer Buy After a Key FDA Win?	Motley Fool	Jun 30
Stocks Rally to Start a Big Holiday Week: Stock Market Today	Kiplinger	Jun 29
MRNA Stock Jumps to 52-Week High on Expansion Plans Beyond Vaccines	Zacks	Jun 29
MRNA Stock Spikes as Moderna Shares mRNA Pipeline Update	Barchart	Jun 29

Industry Peers